Latest reported quarter: Q4, ended Dec 2008 · reported in GBP
Quarter 2025/FY
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
| Line item | 2026 Q2 (GBP) |
2025 ANNUAL (GBP) |
2025 Q4 (GBP) |
2025 Q2 (GBP) |
2024 ANNUAL (GBP) |
|---|---|---|---|---|---|
| Total Assets | £108.39B | £109.29B | £109.29B | £110.23B | £118.90B |
| Total Current Assets | £11.92B | £12.68B | £12.68B | £13.88B | £14.29B |
| Cash and Cash Equivalents & Short-Term Investments | £2.53B | £3.51B | £3.51B | £4.89B | £3.40B |
| -Cash and Cash Equivalents | £2.52B | £3.49B | £3.49B | £4.40B | £2.89B |
| -Short Term Investments | £15.00M | £16.00M | £16.00M | £489.00M | £513.00M |
| -Accounts Receivable | £3.85B | £3.80B | £3.80B | £3.48B | £3.60B |
| -Taxes Receivable | £465.00M | £470.00M | £470.00M | £108.00M | £67.00M |
| Inventory | £4.85B | £4.38B | £4.38B | £5.09B | £4.62B |
| Total Non-Current Assets | £96.47B | £96.61B | £96.61B | £96.35B | £104.61B |
| Net PPE | £4.22B | £4.48B | £4.48B | £4.16B | £4.38B |
| -Long Term Equity Investment | £1.59B | £1.52B | £1.52B | £1.53B | £1.90B |
| Financial Assets | £4.00M | £135.00M | £135.00M | £141.00M | £110.00M |
| Goodwill and Other Intangible Assets | £87.09B | £86.93B | £86.93B | £86.22B | £94.28B |
| Defined Pension Benefit | £919.00M | £880.00M | £880.00M | £841.00M | £937.00M |
| Total Liabilities | £59.79B | £61.15B | £61.15B | £63.05B | £68.90B |
| Total Current Liabilities | £14.28B | £14.52B | £14.52B | £16.00B | £18.74B |
| Payables | £9.58B | £10.46B | £10.46B | £9.42B | £11.23B |
| -Accounts Payable | £8.58B | £9.33B | £9.33B | £8.24B | £9.55B |
| -Total Tax Payable | £1.00B | £1.13B | £1.13B | £1.17B | £1.68B |
| Short-Term Debt and Capital Lease Obligation | £4.02B | £3.36B | £3.36B | £3.30B | £4.31B |
| Current Provisions | £599.00M | £608.00M | £608.00M | £3.09B | £3.04B |
| Total Non-Current Liabilities | £45.52B | £46.62B | £46.62B | £47.05B | £50.16B |
| Long Term Accounts Payable and Other Payables | £35.00M | £484.00M | £484.00M | £586.00M | £685.00M |
| Long Term Debt and Capital Lease Obligation | £31.05B | £31.71B | £31.71B | £31.90B | £32.64B |
| Derivative Product Liabilities | £156.00M | £124.00M | £124.00M | £150.00M | £268.00M |
| Non-Current Liabilities | £3.14B | £3.16B | £3.16B | £3.21B | £4.07B |
| Total Equity | £48.60B | £48.15B | £48.15B | £47.18B | £50.00B |
| Stockholders' Equity | £48.38B | £47.93B | £47.93B | £46.87B | £49.64B |
| Capital Stock | £573.00M | £577.00M | £577.00M | £581.00M | £585.00M |
| -Common Stock | £573.00M | £577.00M | £577.00M | £581.00M | £585.00M |
| Additional Paid-In Capital | £26.68B | £261.00M | £261.00M | £26.67B | £251.00M |
| Retained Earnings | £22.81B | £27.31B | £27.31B | £22.99B | £26.02B |
| Other Equity Interests | £1.89B | £1.89B | £1.89B | £1.69B | £1.69B |
| Minority Interests | £216.00M | £219.00M | £219.00M | £303.00M | £352.00M |
| Restricted Cash | – | £335.00M | £335.00M | – | £2.41B |
| -Gross PPE | – | £9.28B | £9.28B | – | £8.85B |
| -Accumulated Depreciation | – | -£4.79B | -£4.79B | – | -£4.47B |
| -Available for Sale Securities | – | £277.00M | £277.00M | – | £65.00M |
| -Goodwill | – | £38.92B | £38.92B | – | £41.13B |
| -Other Intangible Assets | – | £48.02B | £48.02B | – | £53.15B |
| -Current Debt | – | £3.21B | £3.21B | – | £4.17B |
| -Current Capital Lease Obligation | – | £153.00M | £153.00M | – | £141.00M |
| -Long Term Debt | – | £31.33B | £31.33B | – | £32.19B |
| -Long Term Capital Lease Obligation | – | £376.00M | £376.00M | – | £444.00M |
| Less: Treasury Stock | – | £4.38B | £4.38B | – | £4.41B |
| Line item | 2025 ANNUAL (GBP) |
2024 ANNUAL (GBP) |
2023 ANNUAL (GBP) |
2022 ANNUAL (GBP) |
2021 ANNUAL (GBP) |
|---|---|---|---|---|---|
| Total Revenue as Reported | £25.61B | £25.87B | £27.28B | £27.66B | £25.68B |
| Total Operating Revenue | £25.61B | £25.87B | £27.28B | £27.66B | £25.68B |
| Cost of Revenue | £4.23B | £4.44B | £4.64B | £4.55B | £4.38B |
| Gross Profit | £21.38B | £21.43B | £22.64B | £23.10B | £21.30B |
| Operating Expense | £9.73B | £10.80B | £31.18B | £8.82B | £7.94B |
| Selling and Admin Expenses | £1.12B | £1.14B | £1.18B | £1.19B | £1.27B |
| -Selling & Marketing Expense | £1.09B | £1.11B | £1.15B | £1.16B | £1.24B |
| -General & Admin Expense | £31.00M | £30.00M | £29.00M | £29.00M | £27.00M |
| Research & Development | £133.00M | £174.00M | £181.00M | £138.00M | £141.00M |
| -Depreciation & Amortization | £2.27B | £3.06B | £24.00B | £1.31B | £1.02B |
| Other Operating Expenses | £3.27B | £3.73B | £3.47B | £3.86B | £2.98B |
| Operating Profit | £11.66B | £10.63B | -£8.53B | £14.28B | £13.36B |
| Net Non-Operating Interest Income (Expense) | -£1.73B | -£1.59B | -£1.72B | -£1.59B | -£1.49B |
| Non-Operating Interest Income | £214.00M | £251.00M | £186.00M | £92.00M | £35.00M |
| Non-Operating Interest Expense | £1.93B | £1.82B | £1.89B | £1.66B | £1.49B |
| Total Other Finance Costs | £17.00M | £17.00M | £19.00M | £21.00M | £33.00M |
| Special Income (Charges) | -£1.60B | -£7.29B | -£7.24B | -£3.63B | -£3.12B |
| -Less:Restructuring and Mergern & Acquisition | £75.00M | – | – | – | – |
| -Less:Other Special Charges | £1.03B | £7.12B | £2.38B | £3.38B | £2.84B |
| -Less:Write Off | £217.00M | £134.00M | £250.00M | £250.00M | £215.00M |
| Pretax Profit | £9.86B | £3.54B | -£17.06B | £9.32B | £9.16B |
| Tax | £2.09B | £357.00M | -£2.87B | £2.48B | £2.19B |
| Net Profit | £7.77B | £3.18B | -£14.19B | £6.85B | £6.97B |
| Profit from Continuing Operations | £7.77B | £3.18B | -£14.19B | £6.85B | £6.97B |
| Minority Interests | £1.00M | £113.00M | £178.00M | £180.00M | £173.00M |
| Net Income to Parent Company | £7.76B | £3.07B | -£14.37B | £6.67B | £6.80B |
| Other Preferred Stock Dividends | £87.00M | £42.00M | £45.00M | £49.00M | £12.00M |
| Net Income to Common Stockholders | £7.68B | £3.03B | -£14.41B | £6.62B | £6.79B |
| Basic EPS | £3.51 | £1.37 | -£6.47 | £2.93 | £2.97 |
| Diluted EPS | £3.49 | £1.36 | -£6.47 | £2.92 | £2.96 |
| Dividend Per Share | £2.40 | £2.33 | £2.33 | £2.18 | £2.18 |
| Other Non-Operating Income (Expenses) | – | -£10.00M | -£9.00M | -£5.00M | -£3.00M |
| Line item | 2025 ANNUAL (GBP) |
2024 ANNUAL (GBP) |
2023 ANNUAL (GBP) |
2022 ANNUAL (GBP) |
2021 ANNUAL (GBP) |
|---|---|---|---|---|---|
| Operating Cash Flow | £6.34B | £10.13B | £10.71B | £10.39B | £9.72B |
| Net Income from Continuing Operations | £7.77B | £3.18B | -£14.19B | £6.85B | £6.97B |
| Deferred Tax | £2.09B | £357.00M | -£2.87B | £2.48B | £2.19B |
| Other Non-Cash Items | £1.93B | £958.00M | £2.19B | £2.20B | £1.92B |
| Change in Working Capital | -£3.91B | £5.78B | -£469.00M | £103.00M | -£62.00M |
| -Change in Receivables | -£295.00M | -£269.00M | -£487.00M | -£42.00M | -£393.00M |
| -Change in Inventory | £112.00M | £35.00M | £265.00M | -£246.00M | £433.00M |
| Net cash flow from investing | £1.39B | £1.38B | -£296.00M | -£705.00M | -£1.14B |
| Net PPE Purchase and Sale | -£514.00M | -£341.00M | -£406.00M | -£492.00M | -£496.00M |
| Net Intangibles Purchase and Sale | -£122.00M | -£83.00M | -£114.00M | -£130.00M | -£218.00M |
| Net Business Purchase and Sale | £1.03B | £1.53B | £122.00M | -£39.00M | -£231.00M |
| Net Investment Purchase and Sale | £794.00M | £83.00M | -£43.00M | -£129.00M | -£228.00M |
| Net Other Investing Changes | £1.00M | – | – | – | – |
| Financing Cash Flow | -£8.76B | -£10.63B | -£9.31B | -£8.88B | -£8.75B |
| Net Issuance Payments Of Debt | -£118.00M | -£2.42B | -£1.64B | £223.00M | -£3.87B |
| Net Common Stock Issuance | -£1.17B | -£792.00M | -£110.00M | -£2.09B | -£82.00M |
| Cash Dividends Paid | -£5.24B | -£5.21B | -£5.06B | -£4.92B | -£4.90B |
| Net Other Financing Charges | -£231.00M | -£123.00M | -£476.00M | -£112.00M | £1.91B |
| Ending Cash Balance | £3.79B | £5.10B | £4.52B | £3.34B | £2.46B |
| Net Change in Cash | -£1.03B | £868.00M | £1.10B | £811.00M | -£172.00M |
| Beginning Cash Balance | £5.10B | £4.52B | £3.34B | £2.46B | £2.89B |
| Effect of Exchange Rate Changes | -£76.00M | -£281.00M | -£292.00M | £431.00M | -£253.00M |
| Free Cash Flow | £5.64B | £9.52B | £10.11B | £9.74B | £8.97B |